Nxera Pharma Co (TSE:4565) Margin of Safety % (DCF FCF Based): N/A (As of Jun. 26, 2026)


TSE:4565 Nxera Pharma Co Ltd TSE:4565
73 GF Score
Price 円954.00
GF Value 円1,308.23
Valuation Modestly Undervalued
! 7 Warning Signs
View Full Analysis

What is Nxera Pharma Co Margin of Safety % (DCF FCF Based)?

Margin of Safety % (DCF FCF Based) = (Intrinsic Value: DCF (FCF Based) - Current Price) / Intrinsic Value: DCF (FCF Based).

Note: Discounted FCF model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

Nxera Pharma Co's Predictability Rank is 1-Star. Thus, the DCF related results in the screener and portfolio will appear as zero and Margin of Safety % (DCF FCF Based) is not calculated.

TSE:4565 vs VRTX, REGN, ALNY: Margin of Safety % (DCF FCF Based) Comparison

For the Biotechnology subindustry, Nxera Pharma Co's Margin of Safety % (DCF FCF Based), along with its competitors' market caps and Margin of Safety % (DCF FCF Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Nxera Pharma Co Margin of Safety % (DCF FCF Based) vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Nxera Pharma Co's Margin of Safety % (DCF FCF Based) distribution charts can be found below:

* The bar in red indicates where Nxera Pharma Co's Margin of Safety % (DCF FCF Based) falls into.


TSE:4565
73GF Score
Nxera Pharma Co Ltd TSE:4565
Margin of Safety % (DCF FCF Based) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Nxera Pharma Co (TSE:4565) Overvalued in 2026?

Based on GuruFocus' analysis, Nxera Pharma Co stock appears to be undervalued. The current stock price of 円954.00 is trading 27.1% below its estimated GF Value™ of 円1,308.23. GuruFocus considers Nxera Pharma Co to be Modestly Undervalued.

Key valuation signals for TSE:4565:

  • Margin of Safety % (DCF FCF Based): N/A
  • GF Value™: 円1,308.23 vs. price of 円954.00 (27.1% below fair value)
  • GF Score™: 73/100 with 7 warning signs

No single metric tells the full story. See the TSE:4565 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Nxera Pharma Co Business Description

Other Exchanges SOLTF:USA
Address Midtown East, 9-7-2 Akasaka Minato-ku, Tokyo, JPN, 107-0052
Nxera Pharma Co Ltd is a science and technology-led biopharmaceutical company. Its activities are drug discovery, drug development and the commercialization of pharmaceutical products. The focus is to discover new medicines for unmet medical needs, including novel small molecules, peptides and therapeutic antibodies targeting G Protein Coupled Receptors (GPCRs).
73GF Score

Get the complete analysis for TSE:4565

Margin of Safety % (DCF FCF Based) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円954.00
Price
円1,308.23
GF Value